Kenvue is a consumer-staples company that owns brands like Band-Aid and Tylenol, with a dividend yield of 5.5%. Medtronic, a medical-device company, is close to becoming a “Dividend King” with a streak of 48 years of dividend increases. Pfizer, facing industry challenges, offers a high yield of nearly 7%, but with a higher risk due to a nearly 100% dividend-payout ratio and upcoming patent expirations. Investors have three options: low-risk Medtronic, moderate-risk Kenvue, and high-risk Pfizer, each with its own potential for growth.

Investors should carefully consider the risks and rewards of investing in Kenvue, Medtronic, and Pfizer, each offering unique opportunities in the healthcare sector.

Read more at Nasdaq: Got $1,000? 3 High-Yield Healthcare Stocks to Buy and Hold Forever.